spacer
home > epc > winter 2019 > realising international data access through data collaborations
PUBLICATIONS
European Pharmaceutical Contractor

Realising International Data Access through Data Collaborations

International clinical trials and the commercialisation of new precision medicines across global markets require access to real-world data (RWD). With access to RWD on a global scale, pharmaceutical companies are empowered to derive valuable insights that translate into more patients for clinical trials, faster time to market, and increased revenues in international markets.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Randy Ramin-Wright is the Site & Patient Network Director at Clinerion. Randy holds a Bachelor of Science in astrophysics and a Master of Science in physics from the Michigan State University, US. He has more than 20 years’ experience in consulting, risk management, and information management systems implementation.

Le Vin Chin is Head of Marketing and Communications at Clinerion and has been working in communications and marketing for 20 years, in a wide variety of industries, including software and services.
spacer
Randy Ramin-Wright
spacer
spacer
spacer
Le Vin Chin
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

White Papers

PhlexEview: Transforming Costly Paper Processes into Value Driven Compliance

Phlexglobal Ltd

Looking at some of the challenges of traditional paper-based Trial Master Files (TMFs), and how they can be overcome with Phlexglobal's best in breed electronic TMF system, PhlexEview.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on today’s hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement